THE TUMOUR THAT ISN'T

• Harishkumar Aravindababu,*  
• Jefila Jayakumar,  
• Kale Satya Geethika,  
• Abhishek ATM

Abstract

• Case of 18/F presented with C/o diminished vision in LE since childhood, Patient noticed diminution of vision in LE 5 years back during routine school screening which was painless and progressive in nature. On presentation her BCVA in RE - 6/6 and in LE -HM+ PL+ PR ACCURATE IN ALL QUADRANTS, with normal IOP in both eyes. On anterior segment examination she had Grade 1 RAPD In left eye, rest were found to be normal in both eyes. Fundus examination revealed normal fundus in the right eye and Left eye had clear media with Size of 4 – 5DD elevated subretinal greyish yellow lesion noted in posterior pole and peripapillary area with ERM causing apparent traction of retina, With overlying dilated and tortuous vessels. Oct showed Highly reflective elevated lesion with hyporeflective shadowing of underlying tissue & obscuration of normal retinal layers with an epiretinal membrane. Patient was diagnosed as LE: CONGENITAL HAMARTOMA OF RPE. • It has been speculated that OCT could provide useful information regarding potential visual benefit as the more intact retina on OCT might have better visual outcome than the completely disorganized, thickened retina. • Compared with extramacular lesions, macular lesions are associated with younger presentation (mean age 14.2 months old versus 9.5 months old), strabismus (25% versus 31%), and decreased visual acuity (37% versus 43%). • Numerous reports describe an association with neurofibromatosis type 1 and 2. • Gorlin-Goltz syndrome, Poland anomaly, and branchio-oculo-facial syndrome are also associated. • They usually do not show malignant transformation. Choroidal neovascularization may cause vitreous hemorrhage, retinoschisis, and macular hole. • Periodic monitoring is recommended for treatment. The role of epiretinal membrane peeling surgery is controversial.

Keywords

hamartoma of RPE,retina,Choroidal neovascularization ,neurofibromatosis,macular lesions ,OCT